Semin Immunol. 2026 May 2;82:102028. doi: 10.1016/j.smim.2026.102028. Online ahead of print.ABSTRACTChagas disease (ChD) and Type 2 diabetes (T2D) originate from distinct etiological processes -infectious and metabolic, respectively- yet both share a chronic inflammatory and metabolic imbalance that
An Bras Dermatol. 2026 May 2;101(3):501356. doi: 10.1016/j.abd.2026.501356. Online ahead of print.ABSTRACTBACKGROUND: Psoriasis is a chronic immune-mediated inflammatory disease linked to systemic comorbidities such as obesity, diabetes, cardiovascular disease, and inflammatory bowel disease. Non-ph
J Eval Clin Pract. 2026 Jun;32(4):e70465. doi: 10.1111/jep.70465.ABSTRACTINTRODUCTION: ChatGPT is a cost-effective artificial intelligence (AI) tool designed to facilitate virtual interactions with humans, and its application in healthcare is expanding. However, research on ChatGPT's effectiveness i
Prostate. 2026 May 3. doi: 10.1002/pros.70174. Online ahead of print.ABSTRACTBACKGROUND: As overall survival improves in metastatic hormone-sensitive prostate cancer (mHSPC), non-cancer causes of death are increasingly relevant.METHODS: We conducted a real-world multicenter study of patients diagnos
Cancer Med. 2026 May;15(5):e71904. doi: 10.1002/cam4.71904.ABSTRACTBACKGROUND: Cancer therapy-related cardiac dysfunction (CTRCD) is among the most important adverse effects of treatment of childhood cancer. In the EARLY study (Early detection of acute and early-onset cARdiovascuLar toxicity in chil
No abstractQual Life Res. 2026 May 3;35(6):149. doi: 10.1007/s11136-026-04253-5.NO ABSTRACTPMID:42070205 | DOI:10.1007/s11136-026-04253-5
Qual Life Res. 2026 May 3;35(6):148. doi: 10.1007/s11136-026-04263-3.ABSTRACTPURPOSE: The ULTRA trial evaluated the impact of ultra-early and short-term tranexamic acid (TXA) treatment in patients with subarachnoid hemorrhage (SAH) and found no clinical benefit at six months. This post-hoc analysis
No abstractAngiogenesis. 2026 May 3;29(3):30. doi: 10.1007/s10456-026-10045-9.NO ABSTRACTPMID:42070175 | DOI:10.1007/s10456-026-10045-9
Angiogenesis. 2026 May 3;29(3):26. doi: 10.1007/s10456-026-10041-z.ABSTRACTBrain arteriovenous malformations (BAVMs) are increasingly recognized as dynamic vascular diseases driven by endothelial genetic alterations and dysregulated signaling pathways, rather than as static structural anomalies. Acc
Aging Cell. 2026 May;25(5):e70528. doi: 10.1111/acel.70528.ABSTRACTThe loss of chromosome Y (LOY) in leukocytes is the most prevalent form of clonal mosaicism observed in older men. Previous studies provided multiple pieces of evidence for the effect of LOY on the immune system and connected LOY to
J Am Heart Assoc. 2026 May 3:e050299. doi: 10.1161/JAHA.126.050299. Online ahead of print.ABSTRACTBACKGROUND: Bioprosthetic mitral valve degeneration is traditionally treated with redo surgical mitral valve replacement (redo-SMVR), but valve-in-valve transcatheter mitral valve replacement (ViV-TMVR)
Gut Microbes. 2026 Dec 31;18(1):2664712. doi: 10.1080/19490976.2026.2664712. Epub 2026 May 3.ABSTRACTBACKGROUND & AIMS: Proton pump inhibitor (PPI) use has been associated with metabolic dysfunction associated with steatotic liver disease (MASLD) in multiple studies. While the association is confoun
J Cardiothorac Surg. 2026 May 2. doi: 10.1186/s13019-026-04146-1. Online ahead of print.ABSTRACTBACKGROUND: The co-occurrence of mirror-image dextrocardia and tetralogy of Fallot (TOF) is a rare congenital condition. Reoperative multivalve surgery in such patients, especially after repaired TOF, pre
Am J Cardiovasc Drugs. 2026 May 2. doi: 10.1007/s40256-026-00798-5. Online ahead of print.ABSTRACTBACKGROUND/OBJECTIVE: Residual cardiovascular risk persists despite intensive statin therapy in patients with established atherosclerotic cardiovascular disease (CVD). Omega-3 fatty acids, particularly
Curr Microbiol. 2026 May 2;83(6):346. doi: 10.1007/s00284-026-04940-z.ABSTRACTThe gut microbiome supports digestion, immunity, and metabolism; its imbalance (dysbiosis) drives inflammation and metabolic dysfunction, contributing to chronic diseases such as diabetes, cardiovascular disease, inflammat
Pediatr Nephrol. 2026 May 2. doi: 10.1007/s00467-026-07310-w. Online ahead of print.ABSTRACTDespite modest improvement, the lifespan of a child on dialysis continues to be 40 years shorter compared to healthy children. Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in t
Childs Nerv Syst. 2026 May 2;42(1):195. doi: 10.1007/s00381-026-07286-w.ABSTRACTBACKGROUND: Central nervous system (CNS) metastases from Wilms tumor (WT) are exceedingly rare. Intracerebral hemorrhage secondary to metastatic WT is even less common, and the management of such cases is further complic
No abstractInt J Obes (Lond). 2026 May 2. doi: 10.1038/s41366-026-02096-1. Online ahead of print.NO ABSTRACTPMID:42069939 | DOI:10.1038/s41366-026-02096-1
Eur J Pediatr. 2026 May 2;185(5):337. doi: 10.1007/s00431-026-07000-7.ABSTRACTDexmedetomidine (DEX) is increasingly used for neonatal sedation, but safety data remain limited. We conducted a single-center retrospective study including neonates receiving continuous DEX infusion. Cardiorespiratory eve
Commun Biol. 2026 May 2. doi: 10.1038/s42003-026-09977-1. Online ahead of print.ABSTRACTThe genetic architecture of cardiovascular traits is poorly characterised in non-European populations, limiting our understanding of disease aetiology and contributing to health disparities. Here, we analyse the
Nat Commun. 2026 May 2. doi: 10.1038/s41467-026-72490-w. Online ahead of print.ABSTRACTChildren born small for gestational age (SGA) face elevated risks of metabolic, cardiovascular, respiratory, and neurodevelopmental disorders, as well as premature mortality, yet the underlying mechanisms remain o
Cardiovasc Diabetol. 2026 May 2. doi: 10.1186/s12933-026-03200-5. Online ahead of print.ABSTRACTBACKGROUND: The atherogenic index of plasma (AIP) and estimated glucose disposal rate (eGDR) are two composite indices derived from routine metabolic measurements and are associated with cardiocerebrovasc
BMC Med. 2026 May 2. doi: 10.1186/s12916-026-04904-x. Online ahead of print.ABSTRACTBACKGROUND: Dyslipidemia remains a major modifiable contributor to China's cardiovascular disease (CVD) burden, yet large-scale evidence on risk-stratified management gaps is lacking.METHODS: In this nationwide study
J Biomed Sci. 2026 May 2;33(1):43. doi: 10.1186/s12929-026-01245-y.ABSTRACTCurrent treatment for atherosclerotic cardiovascular diseases (ASCVD) mainly focuses on the modification of systemic risk factors, such as hyperglycemia and hyperlipidemia. Despite significant efforts and expanse, achieving e
